SYN1 and congenital rubella syndrome: Collectively, these findings demonstrate that BDT repairs CRS-induced synaptic structural and functional impairments by targeting core synaptic proteins such as PSD-95 and SYN1, providing direct experimental evidence for its role in enhancing synaptic plasticity.